Drospirenone Female Sex Hormones for Preventing Pregnancy CAS 67392-87-4

Основная информация.

наименование товара: дроспиренон
Синонимы: arbolactone
CAS: 67392-87-4
MF: C24H30O3
МВт: 366.49
EINECS: 266-679-2
депутат: 196-200° С
Альфа: -180°(c=0.5, chloroform)
Storage temp: -20°C Freezer
Внешность: Off-White Crystalline Powder

Описание продукта:

В настоящий момент, the only similar characteristics with natural progesterone progesterone progesterone structure with traditional oral contraceptives contained completely different, it is closer to natural progesterone. Drospirenone addition to anti-androgen effect, but also has the role of Salt corticosteroids can prevent sodium and water retention in the body. Not only has excellent contraceptive effect, there will be many positive effects on women’s health. Например, to reduce the acne, skin is more smooth, effective control of body weight.

Применение продукта:

Drospirenone is an ingredient in some birth control pills and hormone replacement therapy. In combination with ethinyl estradiolit is used as contraception, and for women who want contraception it is also approved by the U. С. Управление по контролю за продуктами и лекарствами(FDA) to treat moderate acne and premenstrual dysphoric disorder.

Medical uses

Drospirenone is an ingredient in some birth control pills and hormone replacement therapy. In combination with ethinylestradiol it is used as contraception, and for women who want contraception it is also approved by the U.S. Управление по контролю за продуктами и лекарствами (FDA) to treat moderate acne and premenstrual dysphoric disorder.

Drospirenone is 8–10 times more potent as an antimineralocorticoid relative to spironolactone (3 mg drospirenone is equivalent to about 20–25 mg spironolactone in this regard. It is more potent as an antiandrogen relative to spironolactone also but is less potent relative to cyproterone acetate, having about one-third the potency of this drug. Progestogenic, antimineralocorticoid, and mild antiandrogenic effects have been observed in humans during treatment with drospirenone at a dosage range of 0.5 к 4 mg per day orally. The antimineralocorticoid properties exhibited by drospirenone promote sodium excretion and prevent water retention.

———————————————————————————————————————————————————————————————————————————————————————-

Связаться сейчас